Abstract
Objectives: Analysis of adverse drug reactions (ADR) reports enriches and updates physician’s awareness about the pattern of cutaneous adverse reactions in the population studied and may play an important role to envision the frequency of appearance of reactions to specific drugs and morphological designs. This study intends to portray the clinical profile and causative agents of dermal ADRs in our population.
Methods: All the ADR reporting forms received from February 2021 to February 2023 were scrutinized, and forms with cutaneous ADRs (CADRs) were analyzed. The data about the history of drug intake, names of the drug taken, time lag of appearance of reaction, and clinical examination details were collected from the reports. Demography, prevalence, reaction time morphological pattern, and causative agents of CADRs were evaluated.
Results: Among the CADRs, acute urticaria 53.4 was the most common followed by acute exanthematous reaction 35.8% and lichenoid drug eruption 3.8%. Among the drugs causing CADRs, antibiotics top the list with 47% followed by ATT at 29.7% and iron sucrose 12.9%. Among the antimicrobials, fluoroquinolones 48% top the list followed by cephalosporins 21.6% and penicillins and vancomycin each 8.3%.
Conclusion: Physician’s knowledge about pattern and causative agents of CADR in the specific population can aid in prevention and early management of ADRs and thereby reducing hospitalization.
Publisher
Innovare Academic Sciences Pvt Ltd
Reference15 articles.
1. Al-Raaie F, Banodkar DD. Epidemiological study of cutaneous adverse drug reactions in Oman. Oman Med J 2008;23:21-7. PMID 22567204
2. Mittal N, Gupta M, Singla M. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India. Cutan Ocul Toxicol 2014;33:289-93. doi: 10.3109/15569527.2013.857678, PMID 24517496
3. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001;53:357-79.
4. Murthy AB, Amuthavalli K, Nirmaladevi P, Meenakshi B. Analysis of cutaneous adverse drug reactions in a tertiary care hospital in South Tamil Nadu. Int J Basic Clin Pharmacol 2022;11:97-107. doi: 10.18203/2319-2003.ijbcp20220406
5. Sharma S, Jayakumar D, Dhanya S. Pharmacovigilance of cutaneous adverse drug reactions among patients attending dermatology department at a tertiary care hospital. Indian Dermatol Online J 2019;10:547-54. doi: 10.4103/idoj.IDOJ_419_18, PMID 31544074